Drugs Used in TB and Leprosy
作者： Meenakshi R. Ramanathan , James M. Sanders
DOI: 10.1016/BS.SEDA.2017.06.025
关键词:
摘要: Abstract Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases multidrug-resistant TB (MDR-TB) and extensively drug-resistant (XDR-TB), clinicians are reverting second-line third-line agents, which have proven toxic nature costly. This chapter reviews 2016 data on side effect profiles commonly used medications Mycobacterium leprae infections. Medications covered this include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, rifamycins.
elsevier.com
sci-hub.se 参考文章(76)
Marta Ramírez-Lapausa, José Francisco Pascual Pareja, Raquel Carrillo Gómez, Mónica Martínez-Prieto, Patricia González-Ruano Pérez, Arturo Noguerado Asensio, Retrospective study of tolerability and efficacy of linezolid in patients with multidrug-resistant tuberculosis (1998-2014). Enfermedades Infecciosas Y Microbiologia Clinica. ,vol. 34, pp. 85- 90 ,(2016) , 10.1016/J.EIMC.2015.04.003
Kyoung Lae Kim, Sung Pyo Park, Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level Cutaneous and Ocular Toxicology. ,vol. 35, pp. 228- 232 ,(2016) , 10.3109/15569527.2015.1079784
Ann-Kathrin Strunk, Sandra Ciesek, Julius J. Schmidt, Christian Kühn, Marius M. Hoeper, Tobias Welte, Jan T. Kielstein, Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment. International Journal of Infectious Diseases. ,vol. 42, pp. 1- 3 ,(2016) , 10.1016/J.IJID.2015.10.018
Ibrahim Toker, Murat Yesilaras, Feriyde Caliskan Tur, Rana Toktas, Methemoglobinemia caused by dapsone overdose: Which treatment is best? Turkish journal of emergency medicine. ,vol. 15, pp. 182- 184 ,(2015) , 10.1016/J.TJEM.2014.09.002
Hemanta Kumar Kar, Ruchi Gupta, Treatment of leprosy. Clinics in Dermatology. ,vol. 33, pp. 55- 65 ,(2015) , 10.1016/J.CLINDERMATOL.2014.07.007
KE McColl, GG Thompson, E Omar, MR Moore, BK Park, MJ Brodie, Effect of rifampicin on haem and bilirubin metabolism in man. British Journal of Clinical Pharmacology. ,vol. 23, pp. 553- 559 ,(1987) , 10.1111/J.1365-2125.1987.TB03091.X
M. C. Cholo, H. C. Steel, P. B. Fourie, W. A. Germishuizen, R. Anderson, Clofazimine: current status and future prospects Journal of Antimicrobial Chemotherapy. ,vol. 67, pp. 290- 298 ,(2012) , 10.1093/JAC/DKR444
Tawanda Gumbo, Arnold Louie, Mark R. Deziel, George L. Drusano, Pharmacodynamic Evidence that Ciprofloxacin Failure against Tuberculosis Is Not Due to Poor Microbial Kill but to Rapid Emergence of Resistance Antimicrobial Agents and Chemotherapy. ,vol. 49, pp. 3178- 3181 ,(2005) , 10.1128/AAC.49.8.3178-3181.2005
Elias B. Chahine, Lamis R. Karaoui, Hanine Mansour, Bedaquiline A Novel Diarylquinoline for Multidrug-Resistant Tuberculosis Annals of Pharmacotherapy. ,vol. 48, pp. 107- 115 ,(2014) , 10.1177/1060028013504087
Giovanna Fatiguso, Sarah Allegra, Andrea Calcagno, Lorena Baietto, Ilaria Motta, Fabio Favata, Jessica Cusato, Stefano Bonora, Giovanni Di Perri, Antonio D’Avolio, Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study. International Journal of Pharmaceutics. ,vol. 497, pp. 287- 292 ,(2016) , 10.1016/J.IJPHARM.2015.11.044